Role of Surgical and Medical Management of Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review

被引:0
|
作者
Crowley, Alexandra V. [1 ]
Banfield, Megan [1 ]
Gupta, Aditi [1 ]
Raj, Rhea [1 ]
Gorantla, Vasavi R. [2 ]
机构
[1] St Georges Univ, Sch Med, St Georges, Grenada
[2] West Virginia Sch Osteopath Med, Biomed Sci, Lewisburg, PA USA
关键词
pulmonary hypertension; anticoagulants; balloon pulmonary angioplasty (bpa); pulmonary endarectomy; (pea); thrombus; chronic thromboembolic pulmonary hypertension (cteph); ANGIOPLASTY; ENDARTERECTOMY; OUTCOMES; STATEMENT; RIOCIGUAT; EFFICACY; THERAPY; LIFE;
D O I
10.7759/cureus.53336
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic thromboembolic pulmonary hypertension (CTEPH) is underdiagnosed and has recently surfaced as one of the leading triggers of severe pulmonary hypertension. This disease process is described by structural changes of pulmonary arteries such as fibrous stenosis, complete obliteration, or the presence of a resistant intraluminal thrombus, resulting in increased pulmonary resistance and eventually progressing to rightsided heart failure. Hence, this study aims to describe the current treatments for CTEPH and their efficacy in hemodynamic improvement and prevention of recurring thromboembolic episodes in patients. This systematic review promptly follows the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. On February 13, 2022, our team searched through the following databases: PubMed, ProQuest, and ScienceDirect. The following keywords were used across all databases: CTEPH AND Pulmonary Endarterectomy (PEA), CTEPH AND Balloon Pulmonary Angioplasty (BPA), and CTEPH AND Medical Therapy OR Anticoagulation therapy. Twenty-nine thousand eighty-nine articles on current management techniques (PEA, Balloon angioplasty, anticoagulants) were selected, analyzed, and reviewed with each other. We found 19 articles concerning PEA, 15 concerning BPA, and six regarding anticoagulants. Most papers showed high success rates and promising evidence of PEA and anticoagulants as a postoperative regimen. BPA was the least preferred but is still reputable in patients unfit for invasive techniques. CTEPH is a condition presenting with either fibrous stenosis, complete obliteration of the artery, or a clogged thrombus. Recent studies have shown three techniques that physicians have used to treat CTEPH: balloon-pulmonary angioplasty, PEA, and medical management with anticoagulants. PEA followed by anticoagulants is preferred to balloon pulmonary angioplasties. CTEPH is an ongoing topic in research; as it continues to be researched, we hope to see more management techniques available.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Surgical and Percutaneous Interventions for Chronic Thromboembolic Pulmonary Hypertension
    Auger, William R.
    CARDIOLOGY CLINICS, 2020, 38 (02) : 257 - +
  • [42] Chronic thromboembolic pulmonary hypertension: detection, medical and surgical treatment approach, and current outcomes
    David S. Poch
    William R. Auger
    Heart Failure Reviews, 2016, 21 : 309 - 322
  • [43] Mortality rates in chronic thromboembolic pulmonary hypertension patients: medical versus surgical treatment
    Gude, M. J. Lopez
    Quezada, A.
    Lozano, A. Santos
    Velazquez, T.
    Alonso, S.
    Vela, J. L. Perez
    Sanchez, M. A. Gomez
    Moran, L.
    Romero, J. M. Cortina
    Subias, P. Escribano
    EUROPEAN HEART JOURNAL, 2016, 37 : 359 - 359
  • [44] Effects of Surgical and Medical Treatment on Quality of Life for Patients With Chronic Thromboembolic Pulmonary Hypertension
    Urushibara, Takashi
    Tanabe, Nobuhiro
    Suda, Rika
    Kato, Fumiaki
    Kasai, Hajime
    Takeuchi, Takao
    Sekine, Ayumi
    Nishimura, Rintaro
    Jujo, Takayuki
    Sugiura, Toshihiko
    Shigeta, Ayako
    Sakao, Seiichiro
    Kasahara, Yasunori
    Tatsumi, Koichiro
    CIRCULATION JOURNAL, 2015, 79 (12) : 2696 - 2702
  • [45] Chronic thromboembolic pulmonary hypertension: detection, medical and surgical treatment approach, and current outcomes
    Poch, David S.
    Auger, William R.
    HEART FAILURE REVIEWS, 2016, 21 (03) : 309 - 322
  • [46] Chronic thromboembolic pulmonary hypertension: surgical treatment with thromboendarterectomy
    Antonio Blazquez, Jose
    Escribano, Pilar
    Perez, Enrique
    Jesus Lopez, Maria
    Angel Gomez, Miguel
    Maria Cortina, Jose
    ARCHIVOS DE BRONCONEUMOLOGIA, 2009, 45 (10): : 496 - 501
  • [47] Anticoagulation in chronic thromboembolic pulmonary hypertension: A systematic review and meta-analysis
    Ishisaka, Yoshiko
    Watanabe, Atsuyuki
    Takagi, Hisato
    Steiger, David
    Kuno, Toshiki
    THROMBOSIS RESEARCH, 2023, 231 : 91 - 98
  • [48] Use of direct oral anticoagulants in chronic thromboembolic pulmonary hypertension: a systematic review
    Ramy Sedhom
    Michael Megaly
    Ena Gupta
    Aman Amanullah
    Journal of Thrombosis and Thrombolysis, 2022, 53 : 51 - 57
  • [49] Use of direct oral anticoagulants in chronic thromboembolic pulmonary hypertension: a systematic review
    Sedhom, Ramy
    Megaly, Michael
    Gupta, Ena
    Amanullah, Aman
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022, 53 (01) : 51 - 57
  • [50] Chronic thromboembolic pulmonary hypertension and associated medical conditions
    Bonderman, D.
    Wilkens, H.
    Wakounig, S.
    Schaefers, H. J.
    Jansa, P.
    Simkova, I.
    Martischnig, A.
    Sadushi, R.
    Klepetko, W.
    Lang, I. M.
    EUROPEAN HEART JOURNAL, 2008, 29 : 518 - 519